BioPharma, Pharma AstraZeneca’s Icosavax M&A Deal Helps It Stand Out in Multivalent Vaccines Chase By Frank Vinluan
BioPharma, Pharma Sanofi’s mRNA strategy adds biggest piece yet with $3.2B Translate Bio buyout By Frank Vinluan
Top Story Morning Read: Brexit win throws drug regulation, VC investment in UK life sciences into question By Stephanie Baum
